Trinity Biotech (TRIB) Raw Materials (2016 - 2025)
Trinity Biotech (TRIB) posted quarterly Raw Materials of $11.5 million for Q4 2025, up 14.48% year-on-year from $10.0 million in Q4 2024, and up 14.48% on a QoQ basis from $10.0 million in Q4 2024.
Trinity Biotech (TRIB) Raw Materials (2016 - 2025) Analysis & Trends
Trinity Biotech (TRIB) has reported Raw Materials for 7 consecutive years, with $11.5 million the latest figure, recorded in Q4 2025.
- Quarterly Raw Materials rose 14.48% year-over-year to $11.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $11.5 million (up 14.48% YoY) and the FY2025 annual result came in at $11.5 million, up 14.48% from the prior year.
- Raw Materials grew to $11.5 million in Q4 2025 per TRIB's latest filing, from $10.0 million in the prior quarter.
- Over the last five years, Raw Materials for TRIB reached as high as $11.5 million in Q4 2025 and fell as low as $10.0 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Trinity Biotech | 93,750.00 | -5.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.49 Mn |
| Dec 31, 2024 | 10.03 Mn |
| Dec 31, 2020 | 12.17 Mn |
| Dec 31, 2019 | 12.65 Mn |
| Dec 31, 2018 | 10.56 Mn |
| Dec 31, 2017 | 10.35 Mn |
| Dec 31, 2016 | 9.18 Mn |